Pfizer strikes cancer drug deal with China's 3SBio Ruchika Sharma20 May 2025 11:30 AM IST3SBio plans to initiate the first Phase 3 study in China in 2025.
Pfizer Gets CDSCO Panel Nod To study Anti-cancer Drug Disitamab vedotin Dr. Divya Colin17 May 2025 6:00 PM ISTNew Delhi: Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
Pfizer discontinues development of danuglipron for chronic weight management Ruchika Sharma14 April 2025 5:41 PM ISTNew York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...
GSK, Pfizer resolve patent lawsuit over RSV vaccines Ruchika Sharma8 April 2025 5:10 PM ISTPfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV)...
Pfizer Gets CDSCO Panel Nod To study Marstacimab Dr. Divya Colin4 April 2025 6:00 PM ISTNew Delhi: The pharmaceutical major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer Abrysvo gets European Commission nod for RSV Lower Respiratory Tract Disease in adults aged 18-59 years Ruchika Sharma2 April 2025 4:45 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has issued a decision amending the marketing authorization for...
Sandeep Seth to exit Pfizer as Senior Director - Compliance Ruchika Sharma2 April 2025 11:30 AM ISTMumbai: Pfizer has announced that Sandeep Seth, Senior Director - Compliance, has tendered his resignation from the services of the Company.His...
BioNTech vs CureVac: European Patent Office declares CureVac mRNA patent valid Ruchika Sharma28 March 2025 5:11 PM ISTIn a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac valid.U.S.-listed shares of...
Pfizer Gets CDSCO Panel Nod To Study Anticancer Drug Disitamab vedotin Dr. Divya Colin22 March 2025 6:00 PM ISTNew Delhi: Citing that more geographically distributed government sites shall be included in the study, the Subject Expert Committee (SEC) functional...
Pfizer to exit Haleon Ruchika Sharma19 March 2025 6:30 PM ISTBengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group.As part of the...
Patent infringement: Pfizer convinces US Patent Office to cancel two Moderna coronavirus vaccine patents Ruchika Sharma6 March 2025 5:56 PM ISTPfizer and BioNTech have convinced a U.S. Patent Office tribunal that two patents Moderna accused Pfizer-BioNtech of infringing were invalid. The...
Former FDA director Patrizia Cavazzoni rejoins Pfizer Ruchika Sharma25 Feb 2025 1:30 PM ISTNew York: Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice President.In...
